Tower View Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.17M | Sell |
4,660
-1,241
| -21% | -$267K | 0.52% | 45 |
|
|
2026
Q1 | $1.28M | Buy |
5,901
+974
| +20% | +$216K | 0.66% | 42 |
|
|
2025
Q4 | $1.13M | Buy |
4,927
+4,024
| +446% | +$917K | 0.56% | 43 |
|
|
2025
Q3 | $209K | Sell |
903
-115
| -11% | -$23.4K | 0.11% | 53 |
|
|
2025
Q2 | $189K | Buy |
1,018
+9
| +0.9% | +$1.67K | 0.1% | 63 |
|
|
2025
Q1 | $211K | Sell |
1,009
-8
| -0.8% | -$1.55K | 0.12% | 50 |
|
|
2024
Q4 | $181K | Buy |
1,017
+9
| +0.9% | +$1.66K | 0.1% | 56 |
|
|
2024
Q3 | $199K | Buy |
1,008
+4
| +0.4% | +$747 | 0.11% | 55 |
|
|
2024
Q2 | $172K | Buy |
1,004
+4
| +0.4% | +$663 | 0.1% | 55 |
|
|
2024
Q1 | $182K | Sell |
1,000
-273
| -21% | -$47K | 0.11% | 60 |
|
|
2023
Q4 | $197K | Sell |
1,273
-114
| -8% | -$16.6K | 0.12% | 54 |
|
|
2023
Q3 | $207K | Buy |
1,387
+541
| +64% | +$79.4K | 0.15% | 54 |
|
|
2023
Q2 | $114K | Buy |
846
+197
| +30% | +$28.9K | 0.08% | 62 |
|
|
2023
Q1 | $103K | Sell |
649
-11
| -2% | -$1.68K | 0.07% | 67 |
|
|
2022
Q4 | $107K | Sell |
660
-23
| -3% | -$3.53K | 0.07% | 67 |
|
|
2022
Q3 | $92K | Buy |
683
+84
| +14% | +$12.1K | 0.07% | 69 |
|
|
2022
Q2 | $92K | Hold |
599
| – | – | 0.07% | 70 |
|
|
2022
Q1 | $97K | Buy |
599
+1
| +0.2% | +$145 | 0.05% | 89 |
|
|
2021
Q4 | $81K | Buy |
598
+1
| +0.2% | +$118 | 0.04% | 90 |
|
|
2021
Q3 | $64K | Buy |
597
+432
| +262% | +$49.4K | 0.04% | 95 |
|
|
2021
Q2 | $19K | Sell |
165
-23
| -12% | -$2.59K | 0.01% | 109 |
|
|
2021
Q1 | $20K | Sell |
188
-230
| -55% | -$24.6K | 0.01% | 116 |
|
|
2020
Q4 | $45K | Buy |
418
+134
| +47% | +$12.9K | 0.03% | 104 |
|
|
2020
Q3 | $25K | Buy |
284
+3
| +1% | +$282 | 0.02% | 96 |
|
|
2020
Q2 | $28K | Buy |
281
+4
| +1% | +$352 | 0.02% | 88 |
|
|
2020
Q1 | $21K | Buy |
277
+3
| +1% | +$256 | 0.02% | 84 |
|
|
2019
Q4 | $24K | Buy |
274
+3
| +1% | +$249 | 0.02% | 98 |
|
|
2019
Q3 | $20K | Buy |
271
+5
| +2% | +$343 | 0.02% | 100 |
|
|
2019
Q2 | $19K | Buy |
266
+3
| +1% | +$236 | 0.02% | 98 |
|
|
2019
Q1 | $21K | Buy |
263
+4
| +2% | +$327 | 0.02% | 97 |
|
|
2018
Q4 | $24K | Buy |
259
+3
| +1% | +$264 | 0.02% | 95 |
|
|
2018
Q3 | $24K | Sell |
256
-46
| -15% | -$4.36K | 0.02% | 111 |
|
|
2018
Q2 | $28K | Buy |
302
+3
| +1% | +$293 | 0.03% | 103 |
|
|
2018
Q1 | $28K | Buy |
299
+1
| +0.3% | +$110 | 0.03% | 102 |
|
|
2017
Q4 | $29K | Buy |
+298
| New | +$28.1K | 0.03% | 106 |
|
Other funds holding ABBV
Tower View Wealth Management's ABBV Position: Q2 2026 in Review
Tower View Wealth Management reduced its AbbVie (ABBV) stake by 21% in Q2 2026, selling an estimated $267K and leaving 4,660 shares worth $1.17M. The position accounts for 0.52% of the portfolio, ranked #45.
Tower View Wealth Management first reported a position in ABBV in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.28M in Q1 2026. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Tower View Wealth Management held 4,660 shares of AbbVie worth $1.17M as of Q2 2026.
- Tower View Wealth Management sold 1,241 AbbVie shares in Q2 2026, an estimated $267K.
- AbbVie made up 0.52% of Tower View Wealth Management's portfolio in Q2 2026, its #45 holding.
- Tower View Wealth Management first reported a position in AbbVie in Q4 2017 and has held it in 35 quarters since.
- Tower View Wealth Management's AbbVie position peaked at $1.28M in Q1 2026.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Tower View Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.